Quick Answer
CANNAPHARMARX, INC. reported Total Revenue of $1.36 million for fiscal year 2025.
CANNAPHARMARX, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $1.36M | +66.1% |
| 2024 | $820.1K | — |
| 2023 | $0.00 | — |
| 2022 | $0.00 | — |
| 2021 | $0.00 | — |
| 2020 | $0.00 | — |
| 2019 | $0.00 | — |
| 2018 | $0.00 | — |
| 2017 | $0.00 | — |
| 2016 | $0.00 | — |
| 2015 | $0.00 | — |
| 2014 | $0.00 | — |
| 2013 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $656.6K | +110.3% | +183.5% |
| June 30, 2025 | $231.6K | — | -30.9% |
| March 31, 2025 | $335.3K | +1197.7% | +7.4% |
| September 30, 2024 | $312.2K | — | — |
| June 30, 2024 | $0.00 | — | -100.0% |
| March 31, 2024 | $25.8K | — | — |
| September 30, 2023 | $0.00 | — | — |
| June 30, 2023 | $0.00 | — | — |
- CANNAPHARMARX, INC. showed an increase of +66.1% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from CANNAPHARMARX, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: